Results 181 to 190 of about 23,920 (210)
Some of the next articles are maybe not open access.
ChemInform, 1991
AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
Y.‐K. ZHANG, G.‐Z. XU
openaire +1 more source
AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
Y.‐K. ZHANG, G.‐Z. XU
openaire +1 more source
Biochimica et Biophysica Acta (BBA) - Bioenergetics, 1990
Intact cells of Rhodobacter capsulatus in the presence of myxothiazol were exposed to trains of short flashes of saturating light and the pattern of the absorbance changes due to P870, cytochrome (c + c) and the carotenoids that report on the membrane potential were monitored.
Jones, M. R. +4 more
openaire +3 more sources
Intact cells of Rhodobacter capsulatus in the presence of myxothiazol were exposed to trains of short flashes of saturating light and the pattern of the absorbance changes due to P870, cytochrome (c + c) and the carotenoids that report on the membrane potential were monitored.
Jones, M. R. +4 more
openaire +3 more sources
ChemInform, 2006
AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
Wei Pan +3 more
openaire +1 more source
AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
Wei Pan +3 more
openaire +1 more source
Chemistry – A European Journal, 2012
AbstractAsymmetric reactions involving (E)‐3‐aryl‐1‐(pyridin‐2‐yl‐N‐oxide)prop‐2‐en‐1‐ones and cyclic enol silyl ethers show good yields and excellent enantioselectivities (up to 99.9 % ee) when catalysed by bis(oxazoline)–CuII complexes. Different reaction pathways can be followed by different enol silyl ethers: with 2‐(trimethylsilyloxy)furan, a ...
LIVIERI, ALESSANDRO +3 more
openaire +3 more sources
AbstractAsymmetric reactions involving (E)‐3‐aryl‐1‐(pyridin‐2‐yl‐N‐oxide)prop‐2‐en‐1‐ones and cyclic enol silyl ethers show good yields and excellent enantioselectivities (up to 99.9 % ee) when catalysed by bis(oxazoline)–CuII complexes. Different reaction pathways can be followed by different enol silyl ethers: with 2‐(trimethylsilyloxy)furan, a ...
LIVIERI, ALESSANDRO +3 more
openaire +3 more sources
Journal of Medicinal Chemistry, 1996
A C-4 hydroxylated metabolite (2, 3,3-dimethyl-3,4-dihydroisoquinolin-4-ol N-oxide) of the previously described cyclic nitrone free radical trap 1 (3,3-dimethyl-3,4-dihydroisoquinoline N-oxide, a cyclic analog of phenyl-tert-butylnitrone (PBN)) was isolated, identified, and synthesized.
C E, Thomas +13 more
openaire +2 more sources
A C-4 hydroxylated metabolite (2, 3,3-dimethyl-3,4-dihydroisoquinolin-4-ol N-oxide) of the previously described cyclic nitrone free radical trap 1 (3,3-dimethyl-3,4-dihydroisoquinoline N-oxide, a cyclic analog of phenyl-tert-butylnitrone (PBN)) was isolated, identified, and synthesized.
C E, Thomas +13 more
openaire +2 more sources
Drug Metabolism and Disposition, 2007
[7-(2,6-Dichloro-phenyl)-5-methyl-benzo[1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amine (TG100435) is a novel multi-targeted Src family kinase inhibitor with demonstrated anticancer activity in preclinical species. Potent kinase inhibition is associated with TG100435 and its major N-oxide metabolite [7-(2,6-dichlorophenyl)-5-methyl ...
Ahmed, Kousba +3 more
openaire +2 more sources
[7-(2,6-Dichloro-phenyl)-5-methyl-benzo[1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amine (TG100435) is a novel multi-targeted Src family kinase inhibitor with demonstrated anticancer activity in preclinical species. Potent kinase inhibition is associated with TG100435 and its major N-oxide metabolite [7-(2,6-dichlorophenyl)-5-methyl ...
Ahmed, Kousba +3 more
openaire +2 more sources
Model iron-catalyzed biomimetic cyclization of a cyclic tryptamine N-oxide
The Journal of Organic Chemistry, 1972C A, Scherer +3 more
openaire +2 more sources
Photoelectron spectra of cyclic azo N-oxides and azo N,N'-dioxides
The Journal of Organic Chemistry, 1977openaire +1 more source

